Sphingosine 1-phosphate-mediated α 1B-adrenoceptor desensitization and phosphorylation. Direct and paracrine/autocrine actions

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 2, 2012, Pages 245-254

  Castillo Badillo, Jean A ^a   Molina Muñoz, Tzindilú ^a   Romero Ávila, M Teresa ^a   Vázquez Macías, Aleida ^a   Rivera, Richard ^b   Chun, Jerold ^b   García Sáinz, J Adolfo ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

1B Adrenergic receptor; 1B Adrenoceptor; EGF receptor; Sphingosine 1 phosphate; Transactivation

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; ENHANCED GREEN FLUORESCENT PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; SPHINGOSINE 1 PHOSPHATE;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CATALYSIS; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VITRO STUDY; MOLECULAR INTERACTION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; AUTOCRINE COMMUNICATION; FIBROBLASTS; HUMANS; LYSOPHOSPHOLIPIDS; PARACRINE COMMUNICATION; PHOSPHORYLATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, LYSOSPHINGOLIPID; SPHINGOSINE;

RATTUS;

EID: 84855763390     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.10.002     Document Type: Article

References (52)

1. Hieble J.P., Bylund D.B., Clarke D.E., Eikenburg D.C., Langer S.Z., Lefkowitz R.J., Minneman K.P., Ruffolo R.R. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol. Rev. 1995, 47:267-270.
2. García-Sáinz J.A., Vázquez-Prado J., Medina L.C. Alpha 1-adrenoceptors: function and phosphorylation. Eur. J. Pharmacol. 2000, 389:1-12.
3. Lefkowitz R.J. Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol. Sci. 2004, 25:413-422.
4. Koshimizu T.A., Yamauchi J., Hirasawa A., Tanoue A., Tsujimoto G. Recent progress in alpha 1-adrenoceptor pharmacology. Biol. Pharm. Bull. 2002, 25:401-408.
5. Cotecchia S., Schwinn D.A., Randall R.R., Lefkowitz R.J., Caron M.G., Kobilka B.K. Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:7159-7163.
6. Diviani D., Lattion A.L., Larbi N., Kunapuli P., Pronin A., Benovic J.L., Cotecchia S. Effect of different G protein-coupled receptor kinases on phosphorylation and desensitization of the alpha1B-adrenergic receptor. J. Biol. Chem. 1996, 271:5049-5058.
7. Iacovelli L., Franchetti R., Grisolia D., De Blasi A. Selective regulation of G protein-coupled receptor-mediated signaling by G protein-coupled receptor kinase 2 in FRTL-5 cells: analysis of thyrotropin, alpha(1B)-adrenergic, and A(1) adenosine receptor-mediated responses. Mol. Pharmacol. 1999, 56:316-324.
8. Diviani D., Lattion A.L., Cotecchia S. Characterization of the phosphorylation sites involved in G protein-coupled receptor kinase- and protein kinase C-mediated desensitization of the alpha1B-adrenergic receptor. J. Biol. Chem. 1997, 272:28712-28719.
9. Casas-González P., García-Sáinz J.A. Role of epidermal growth factor receptor transactivation in alpha1B-adrenoceptor phosphorylation. Eur. J. Pharmacol. 2006, 542:31-36.
10. Casas-González P., Ruiz-Martínez A., García-Sáinz J.A. Lysophosphatidic acid induces alpha-1b-adrenergic receptor phosphorylation through G-beta-gamma, phosphoinositide 3-kinase, protein kinase C and epidermal growth factor receptor transactivation. Biochim. Biophys. Acta 2003, 1633:75-83.
11. Casas-González P., Vázquez-Prado J., García-Sáinz J.A. Lysophosphatidic acid modulates alpha(1b)-adrenoceptor phosphorylation and function: roles of Gi and phosphoinositide 3-kinase. Mol. Pharmacol. 2000, 57:1027-1033.
12. González-Arenas A., Aguilar-Maldonado B., Avendaño-Vázquez S.E., García-Sáinz J.A. Estrogens cross-talk to alpha1b-adrenergic receptors. Mol. Pharmacol. 2006, 70:154-162.
13. Medina L.C., Vázquez-Prado J., García-Sáinz J.A. Cross-talk between receptors with intrinsic tyrosine kinase activity and alpha1b-adrenoceptors. Biochem. J. 2000, 350(Pt 2):413-419.
14. Medina L.C., Vázquez-Prado J., Torres-Padilla M.E., Mendoza-Mendoza A., Cruz Muñoz M.E., García-Sáinz J.A. Crosstalk: phosphorylation of alpha1b-adrenoceptors induced through activation of bradykinin B2 receptors. FEBS Lett. 1998, 422:141-145.
15. Molina-Muñoz T., Romero-Ávila M.T., Avendaño-Vázquez S.E., García-Sáinz J.A. Phosphorylation, desensitization and internalization of human alpha(1B)-adrenoceptors induced by insulin-like growth factor-I. Eur. J. Pharmacol. 2008, 578:1-10.
16. Molina-Muñoz T., Romero-Ávila M.T., García-Sáinz J.A. Insulin-like growth factor-I induces {alpha}1B-adrenergic receptor phosphorylation through G{beta}{gamma} and epidermal growth factor receptor transactivation. Mol. Endocrinol. 2006, 20:2773-2783.
17. Romero-Ávila M.T., Flores-Jasso C.F., García-Sáinz J.A. alpha1B-Adrenergic receptor phosphorylation and desensitization induced by transforming growth factor-beta. Biochem. J. 2002, 368:581-587.
18. Vázquez-Prado J., Medina L.C., García-Sáinz J.A. Activation of endothelin ETA receptors induces phosphorylation of alpha1b-adrenoreceptors in Rat-1 fibroblasts. J. Biol. Chem. 1997, 272:27330-27337.
19. Alcántara-Hernández R., Vázquez-Prado J., García-Sáinz J.A. Protein phosphatase-protein kinase interplay modulates alpha 1b-adrenoceptor phosphorylation: effects of okadaic acid. Br. J. Pharmacol. 2000, 129:724-730.
20. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996, 379:557-560.
21. Zwick E., Hackel P.O., Prenzel N., Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol. Sci. 1999, 20:408-412.
22. Patel T.B. Single transmembrane spanning heterotrimeric g protein-coupled receptors and their signaling cascades. Pharmacol. Rev. 2004, 56:371-385.
23. Alvarez S.E., Milstien S., Spiegel S. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol. Metab. 2007, 18:300-307.
24. Hobson J.P., Rosenfeldt H.M., Barak L.S., Olivera A., Poulton S., Caron M.G., Milstien S., Spiegel S. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 2001, 291:1800-1803.
25. Leclercq T.M., Pitson S.M. Cellular signalling by sphingosine kinase and sphingosine 1-phosphate. IUBMB Life 2006, 58:467-472.
26. Pyne S., Lee S.C., Long J., Pyne N.J. Role of sphingosine kinases and lipid phosphate phosphatases in regulating spatial sphingosine 1-phosphate signalling in health and disease. Cell. Signal. 2009, 21:14-21.
27. Chun J., Goetzl E.J., Hla T., Igarashi Y., Lynch K.R., Moolenaar W., Pyne S., Tigyi G. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 2002, 54:265-269.
28. García-Sáinz J.A., Romero-Ávila M.T., Medina L.C. Dissecting how receptor tyrosine kinases modulate G protein-coupled receptor function. Eur. J. Pharmacol. 2010, 648:1-5.
29. Pitson S.M., Moretti P.A., Zebol J.R., Xia P., Gamble J.R., Vadas M.A., D'Andrea R.J., Wattenberg B.W. Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase. J. Biol. Chem. 2000, 275:33945-33950.
30. García-Sáinz J.A., Casas-González P., Romero-Ávila M.T., González-Espinosa C. Characterization of the hepatic alpha 1B-adrenoceptors of rats, mice and hamsters. Life Sci. 1994, 54:1995-2003.
31. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
32. Avendaño-Vázquez S.E., García-Caballero A., García-Sáinz J.A. Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1. Biochem. J. 2005, 385:677-684.
33. Yamamoto M., Okumura S., Schwencke C., Sadoshima J., Ishikawa Y. High efficiency gene transfer by multiple transfection protocol. Histochem. J. 1999, 31:241-243.
34. Paddison P.J., Cleary M., Silva J.M., Chang K., Sheth N., Sachidanandam R., Hannon G.J. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat. Methods 2004, 1:163-167.
35. Goparaju S.K., Jolly P.S., Watterson K.R., Bektas M., Alvarez S., Sarkar S., Mel L., Ishii I., Chun J., Milstien S., Spiegel S. The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol. Cell. Biol. 2005, 25:4237-4249.
36. King K.E., Iyemere V.P., Weissberg P.L., Shanahan C.M. Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor beta 1 in the regulation of vascular smooth muscle cell phenotype. J. Biol. Chem. 2003, 278:11661-11669.
37. Olivera A., Spiegel S. Sphingosine kinase. Assay and product analysis. Methods Mol. Biol. 1998, 105:233-242.
38. Rasband W.S. ImageJ 1997-2004, National Institutes of Health. http://rsb.info.nih.gov/ij/.
39. Vázquez-Prado J., Medina L.C., Romero-Ávila M.T., González-Espinosa C., García-Sáinz J.A. Norepinephrine- and phorbol ester-induced phosphorylation of alpha(1a)-adrenergic receptors. Functional aspects. J. Biol. Chem. 2000, 275:6553-6559.
40. Adams T.E., Epa V.C., Garrett T.P., Ward C.W. Structure and function of the type 1 insulin-like growth factor receptor. Cell. Mol. Life Sci. 2000, 57:1050-1093.
41. Abarca B., Ballesteros R., Bielsa P., Moragues J., D'Ocon P., García-Zaragoza E., Noguera M.A. Opposite vascular activity of (R)-apomorphine and its oxidised derivatives. Endothelium-dependent vasoconstriction induced by the auto-oxidation metabolite. Eur. J. Med. Chem. 2003, 38:501-511.
42. Toker A., Cantley L.C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 1997, 387:673-676.
43. Shida D., Kitayama J., Yamaguchi H., Yamashita H., Mori K., Watanabe T., Yatomi Y., Nagawa H. Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells. FEBS Lett. 2004, 577:333-338.
44. Yogi A., Callera G.E., Aranha A.B., Antunes T.T., Graham D., McBride M., Dominiczak A., Touyz R.M. Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension. Hypertension 2011, 57:809-818.
45. Kim J.H., Song W.K., Chun J.S. Sphingosine 1-phosphate activates Erk-1/-2 by transactivating epidermal growth factor receptor in rat-2 cells. IUBMB Life 2000, 50:119-124.
46. Sukocheva O., Wadham C., Holmes A., Albanese N., Verrier E., Feng F., Bernal A., Derian C.K., Ullrich A., Vadas M.A., Xia P. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J. Cell Biol. 2006, 173:301-310.
47. Sanden C., Broselid S., Cornmark L., Andersson K., Daszkiewicz-Nilsson J., Martensson U.E., Olde B., Leeb-Lundberg L.M. G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments. Mol. Pharmacol. 2011, 79:400-410.
48. Duvernay M.T., Wang H., Dong C., Guidry J.J., Sackett D.L., Wu G. {alpha}2B-Adrenergic receptor interaction with tubulin controls its transport from the endoplasmic reticulum to the cell surface. J. Biol. Chem. 2011, 286:14080-14089.
49. Pyne N.J., Pyne S. Sphingosine 1-phosphate and cancer. Nat. Rev. Cancer 2010, 10:489-503.
50. Gschwind A., Fischer O.M., Ullrich A. The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat. Rev. Cancer 2004, 4:361-370.
51. Leserer M., Gschwind A., Ullrich A. Epidermal growth factor receptor signal transactivation. IUBMB Life 2000, 49:405-409.
52. García-Sáinz J.A., Vázquez-Prado J., Villalobos-Molina R. Alpha 1-adrenoceptors: subtypes, signaling, and roles in health and disease. Arch. Med. Res. 1999, 30:449-458.